Bicycle Therapeutics Plc - ADR Stock, NASDAQ:BCYC
Building 900, Babraham Research Campus, Cambridge, Cambridgeshire CB22 3AT
Number of Employees: 87
Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in developing a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. The firm utilizes its novel and proprietary phage display screening platform to identify bicycles. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.